88 related articles for article (PubMed ID: 28766347)
1. Effects of ceranib-2 on cell survival and TNF-alpha in colon cancer cell line.
Baspinar M; Ozyurt R; Kus G; Kutlay O; Ozkurt M; Erkasap N; Kabadere S; Yasar NF; Erkasap S
Bratisl Lek Listy; 2017; 118(7):391-393. PubMed ID: 28766347
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.
Kus G; Kabadere S; Uyar R; Kutlu HM
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1056-63. PubMed ID: 26170224
[TBL] [Abstract][Full Text] [Related]
3. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
5. The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro.
Yildiz-Ozer M; Oztopcu-Vatan P; Kus G
Cytotechnology; 2018 Feb; 70(1):387-396. PubMed ID: 29230631
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a ceramidase inhibitor (ceranib-2) with C2 ceramide and cisplatin on cytotoxicity and apoptosis of glioma cells.
Kuş G; Özkurt M; Öztopcu Vatan P; Erkasap N; Uyar R; Kabadere S
Turk J Biol; 2018; 42(3):259-265. PubMed ID: 30814888
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ceramidase inhibition on human renal cell carcinoma: a cell culture study.
Palit F; Vejselova Sezer C; Kutlu HM
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):121-129. PubMed ID: 37869957
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and Apoptotic Impacts of Ceranib-2 on RAW 264.7 Macrophage Cells.
Alanyalı FS; Algı O
Anticancer Agents Med Chem; 2023; 23(20):2183-2188. PubMed ID: 36397616
[TBL] [Abstract][Full Text] [Related]
9. Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.
Vejselova D; Kutlu HM; Kuş G
Cytotechnology; 2016 Dec; 68(6):2721-2728. PubMed ID: 27380965
[TBL] [Abstract][Full Text] [Related]
10. Ceranib-2-induced suicidal erythrocyte death.
Signoretto E; Zierle J; Bhuyan AA; Castagna M; Lang F
Cell Biochem Funct; 2016 Jul; 34(5):359-66. PubMed ID: 27291470
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic effects of ceranib-2 in combination with radiation therapy on human breast cancer cells.
Tuğrul F; Vejselova Sezer C; Kutlu HM
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2322-2328. PubMed ID: 38567595
[TBL] [Abstract][Full Text] [Related]
12. Discovery and evaluation of inhibitors of human ceramidase.
Draper JM; Xia Z; Smith RA; Zhuang Y; Wang W; Smith CD
Mol Cancer Ther; 2011 Nov; 10(11):2052-61. PubMed ID: 21885864
[TBL] [Abstract][Full Text] [Related]
13. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
14. The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells.
Cholewa K; Parfiniewicz B; Bednarek I; Swiatkowska L; Jezienicka E; Kierot J; Weglarz L
Acta Pol Pharm; 2008; 65(1):75-9. PubMed ID: 18536177
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Efficacy of Ceranib-2 with Nano-Formulation of PEG and Rosin Esters.
Ben Taleb A; Karakuş S; Tan E; Ilgar M; Kutlu Ö; Gözüaçık D; Kutlu HM; Kilislioğlu A
Methods Mol Biol; 2021; 2207():199-220. PubMed ID: 33113138
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
19. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells.
Pajak B; Orzechowski A
Oncol Rep; 2007 Oct; 18(4):1039-45. PubMed ID: 17786371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
